Investigation of the Effectiveness of Tele-pulmonary Rehabilitation After Lung Resection

Lung Cancer Clinical Trial

Official title:

Investigation of the Effectiveness of Tele-pulmonary Rehabilitation After Lung Resection

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05794607
• Other study ID #: DrLutfiKirdarPT
• Status: Not yet recruiting
• Phase: N/A
• Start date: April 1, 2023
• Est. completion date: December 1, 2024

Study information

• Verified date: March 2023
• Source: Dr. Lutfi Kirdar Kartal Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

As a result of the review in the literature, no study was found in which tele-pulmonary rehabilitation was applied after physiotherapist-supervised lung resection via video conferencing.

Therefore, in this study, it was planned to investigate the effectiveness of tele-pulmonary rehabilitation in patients diagnosed with lung cancer and undergoing lung resection.

Description:

Research; It was planned as a prospective and randomized controlled study. The research universe is Istanbul Kartal Dr. Lütfi Kırdar City Hospital Chest Surgery Clinic will consist of cases with a preliminary diagnosis of lung cancer. The sample of the study, on the other hand, will consist of patients who agreed to participate in the study and who met the inclusion criteria, who were planned for lung resection.

1. Study group (n=18); The treatment features of the tele-pulmonary rehabilitation group via videoconferencing are; Within the scope of the tele-pulmonary rehabilitation program, an exercise program consisting of lower-upper extremity strengthening training and flexibility training, breathing exercises training (diaphragmatic breathing, thoracic expansion exercises and forced expiration) and aerobic exercise training will be created before discharge, exercise session will be followed. Re-evaluation will be done after 8 weeks.Exercise intensity will be planned as 2 days a week with supervision and 1 day without supervision, 3 days a week in total. Exercise safety will be ensured by taking the severity of shortness of breath of the patients as a reference.

2. Control group (n=18); Patients in the tele-pulmonary rehabilitation control group will be given respiratory and aerobic exercise advice before discharge. Re-evaluation will be done after 8 weeks.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 36
• Est. completion date: December 1, 2024
• Est. primary completion date: April 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 55 Years to 75 Years

Eligibility

Inclusion Criteria:

• Male and female patients aged 55-75 years diagnosed with lung cancer

• Patients who underwent lobectomy, segmentectomy, bilobectomy, and pneumonectomy by either VATS or thoracotomy surgeries

• Patients who can use phones and make video calls

Exclusion Criteria:

• Patients with heart failure or atrial fibrillation

• Patients with acute infection at the time of assessment

• Patients who have had myocardial infarction in the last six months

• Patients with any comorbidities such as uncontrolled diabetes mellitus and/or hypertension

• Patients with any problem that would limit physical activity

Related Conditions & MeSH terms

• Lung Cancer
• Lung Resection

Intervention

Other:
• Rehabilitation group
The intervention group will be given strength training to improve muscle strength and flexibility, and aerobic exercise training to improve exercise capacity with function.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Halime Sinem Barutçu

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Functional exercises capacity	A 6-minute walk test will be performed to determine functional exercise capacity.	8 weeks
Primary	Pulmonary function test	Pulmonary function test will be made in accordance with ats criteria	8 weeks
Primary	Peripheral muscle strength	Peripheral muscle strength will be done with 'Lafayette' device	8 weeks
Primary	Upper extremity normal range of motion	Upper extremity normal range of motion will be measured with a manual goniometer	8 weeks
Secondary	Anxiety and depression	Hospital anxiety and depression scale (HAD scale); It will be used to measure and evaluate patients' anxiety and depression scales.	8 weeks
Secondary	Determination of quality of life	EORTC QLQ-C30; This scale is a widely used quality of life scale in cancer patients all over the world.	8 weeks
Secondary	Cognitive functions	Mini mental state test; will be used to evaluate postoperative cognitive dysfunction.	8 weeks